We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » Drug Regulation in China - Webinar Recording/Transcript

Other Options

USB Audio Recording/Transcript - Sept. 24, 2019

$287.00

USB Audio Recording/Transcript - Sept. 24, 2019

$258.00

USB Audio Recording/Transcript - Sept. 24, 2019

$244.00

USB Audio Recording/Transcript - Sept. 24, 2019

$230.00

USB Audio Recording/Transcript - Sept. 24, 2019

$215.00
webinar recording

Drug Regulation in China - Webinar Recording/Transcript

$287.00
Webinar Recordings

Product Details

Drug Regulation in China: Updates, Key Issues and Common Challenges

Do you do business in China?  Or consider entering the Chinese market?

With the fluidity — and uncertainty — of today’s regulatory environment, you must understand exactly what China has implemented, what is pending and what the near future holds. 

John Balzano, Esq., a partner at Covington & Burling LLP, will provide you with an up-to-date understanding of China’s ever-changing drug regulations, including the proposals to the Drug Administration Law, Drug Registration Regulations, related guidance documents and Human Genetic Resource (HGR) regulations.

Mr. Balzano will present key issues and common challenges for companies navigating the drug regulatory lifecycle in China.

Presentation Takeaways:

  • Important new regulatory reforms in China related to drug development, including 60-day notification of clinical trial applications, priority review and GCP enforcement
  • Revisions to HGR regulations, such as the new notification system and the continued approval system for exploratory research
  • How to prepare for overseas inspections and compliance with emerging distribution and manufacturing rules
  • How to make sense of the recent guidance documents coming out of China including guidance on foreign data and new application modules

Make the recent drug regulations in China work for you.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing